The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Pharmacotherapy of addictions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Psychopharmacology: The third generation of progress
O'Connell, R. A. (1988) · Comprehensive Psychiatry · doi:10.1016/0010-440x(88)90057-0 · Cited by 3,013
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Molecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053570 · Cited by 1,859
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Self-citationNeuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,014
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior
McFarland, K., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08655.2001 · Cited by 905
The Effects of Psychosocial Services in Substance Abuse Treatment
McLellan, A. T. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500150065028 · Cited by 869
Psychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Neuropsychopharmacology : The Fifth Generation of Progress
Davis, K. L., Charney, D. S., Coyle, J. T., & Nemeroff, C. B. (2002) · Lippincott Williams & Wilkins eBooks · Cited by 747
Drug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Self-citationPharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.
Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G. I., & Reisine, T. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09932-8 · Cited by 665
Pettit, H. O., Ettenberg, A., Bloom, F. E., & Koob, G. F. (1984) · Psychopharmacology · doi:10.1007/bf00427441 · Cited by 651
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565
Spanagel, R., Herz, A., & Shippenberg, T. S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04963.x · Cited by 539
Bals-Kubik, R., Ableitner, A., Herz, A., & Shippenberg, T. S. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10296-6 · Cited by 524
Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R. S., Donovan, D. M., Miner, L. L., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1544 · Cited by 523
Cocaine self-administration in dopamine-transporter knockout mice
Rocha, B. A., Fumagalli, F., Gainetdinov, R. R., Jones, S. R., Ator, R., Giros, B., Miller, G. W., & Caron, M. G. (1998) · Nature Neuroscience · doi:10.1038/381 · Cited by 522
Sora, I., Wichems, C., Takahashi, N., Li, X.-F., Zeng, Z., Revay, R., Lesch, K.-P., Murphy, D. L., & Uhl, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7699 · Cited by 505
O'Malley, S., Krishnan-Sarin, S., Farren, C., Sinha, R., & Kreek, M. (2002) · Psychopharmacology · doi:10.1007/s002130100919 · Cited by 492
Self-citationRelapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479
Sora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X.-F., Wei, H.-B., Wichems, C., Lesch, K.-P., Murphy, D. L., & Uhl, G. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091039298 · Cited by 477
Ritz, M. C., Cone, E. J., & Kuhar, M. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90132-b · Cited by 465
Compulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Naltrexone and Alcohol Dependence: Role of Subject Compliance
Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411
A Medical Treatment for Diacetylmorphine (Heroin) Addiction
Dole, V. P., & Nyswander, M. (1966) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-196604000-00028 · Cited by 404
Laurel Gorman, A., Elliott, K. J., & Inturrisi, C. E. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13391-2 · Cited by 398
Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges
Weiss, F., & Porrino, L. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03332.2002 · Cited by 327
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
Whitworth, A. B., Oberbauer, H., Fleischhacker, W. W., Lesch, O. M., Walter, H., Nimmerrichter, A., Platz, T., Fischer, F., & Potgieter, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91682-7 · Cited by 320
Keith, D. E., Antón, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., & von Zastrow, M. (1998) · PubMed · Cited by 317
mu-Opioid receptor knockout mice do not self-administer alcohol.
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · PubMed · Cited by 303
DOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Zubieta, J.-K., Gorelick, D. A., Stauffer, R., Ravert, H. T., Dannals, R. F., & Frost, J. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1225 · Cited by 276
Keith, D. E., Anton, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., & Zastrow, M. V. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.377 · Cited by 276
Gear, R. W., Miaskowski, C., Gordon, N. C., Paul, S. M., Heller, P. H., & Levine, J. D. (1999) · Pain · doi:10.1016/s0304-3959(99)00119-0 · Cited by 274
DOUBLE-BLIND RANDOMIZED MULTICENTRE TRIAL OF ACAMPROSATE IN MAINTAINING ABSTINENCE FROM ALCOHOL
(1995) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045720 · Cited by 273
μ opioid receptor gene variants: lack of association with alcohol dependence
Bergen, A. W., Kokoszka, J., Peterson, R., Long, J. C., Virkkunen, M., Linnoila, M., & Goldman, D. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000331 · Cited by 271
A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
Mason, B. J., Salvato, F. R., Williams, L. D., Ritvo, E. C., & Cutler, R. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.719 · Cited by 271
The economic costs of heroin addiction in the United States
Mark, T. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00162-9 · Cited by 271
KREEK, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06683.x · Cited by 258
Self-citationRassnick, S., Pulvirenti, L., & Koob, G. F. (1992) · Psychopharmacology · doi:10.1007/bf02245485 · Cited by 256
d-Methadone Blocks Morphine Tolerance and N-Methyl-d-Aspartate-Induced Hyperalgesia
Davis, A. M., & Inturrisi, C. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38234-5 · Cited by 249
Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F. R., Goldberg, G., Welch, B., & Mantero‐Atienza, E. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00098.x · Cited by 248
Medical safety and side effects of methadone in tolerant individuals
Kreek, M. J. (1973) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1973.03220060039009 · Cited by 247
Self-citationWand, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 246
Kappa opioid inhibition of morphine and cocaine self-administration in rats
Glick, S. D., Maisonneuve, I. M., Raucci, J., & Sydney, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00306-b · Cited by 242
BindingDB (2012) · PubMed · doi:10.7270/q23j3bh2 · Cited by 242
Emmerson, P. J., Liu, M. R., Woods, J. H., & Medzihradsky, F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24051-4 · Cited by 232
Swanson, C. J., Baker, D. A., Carson, D., Worley, P. F., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-09043.2001 · Cited by 230
Repeated cocaine administration upregulates K and μ, but not δ, opioid receptors
Unterwald, E. M., Rubenfeld, J. M., & Kreek, M. J. (1994) · NeuroReport · doi:10.1097/00001756-199408150-00018 · Cited by 229
Self-citationDisulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 228
Enhanced and Delayed Stress-Induced Alcohol Drinking in Mice Lacking Functional CRH1 Receptors
Sillaber, I., Rammes, G., Zimmermann, S., Mahal, B., Zieglgänsberger, W., Wurst, W., Holsboer, F., & Spanagel, R. (2002) · Science · doi:10.1126/science.1069836 · Cited by 220
μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy
Yu, Y., Zhang, L., Yin, X., Sun, H., Uhl, G. R., & Wang, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28869 · Cited by 219
Carroll, K. M., Nich, C., Ball, S. A., McCance, E., Frankforter, T. L., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.95913355.x · Cited by 216
Spangler, R., Unterwald, E. M., & Kreek, M. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90133-a · Cited by 211
Self-citationTreatment of opioid-induced constipation with oral naloxone: A pilot study
Culpepper-Morgan, J. A., Inturrisi, C. E., Portenoy, R. K., Foley, K., Houde, R. W., Marsh, F., & Kreek, M. J. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.106 · Cited by 208
Self-citationCocaine self-administration differentially alters mRNA expression of striatal peptides
Hurd, Y. L., Brown, E. E., Finlay, J. M., Fibiger, H. C., & Gerfen, C. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90058-j · Cited by 200
Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats
Roberts, D. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(96)00002-4 · Cited by 193
Naloxone Increases ACTH and Cortisol Levels in Man
(1979) · New England Journal of Medicine · doi:10.1056/nejm197905033001817 · Cited by 188
Haney, M., Ward, A., Foltin, R., & Fischman, M. (2001) · Psychopharmacology · doi:10.1007/s002130100725 · Cited by 186
Acamprosate in alcohol dependence: how does it work?
LITTLETON, J. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 178
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s002130100909 · Cited by 175
Maisonneuve, I. M., Archer, S., & Glick, S. D. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90559-2 · Cited by 172
Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum
Daunais, J. B., Roberts, D. C. S., & McGinty, J. F. (1993) · NeuroReport · doi:10.1097/00001756-199305000-00020 · Cited by 168
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients
Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01198-6 · Cited by 168
Dykstra, L. A., Gmerek, D. E., Winger, G., & Woods, J. H. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39097-x · Cited by 168
Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys
Negus, S. S., Mello, N. K., Portoghese, P. S., & Lin, C.-E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36769-2 · Cited by 167
Selley, D. E., Liu, Q., & Childers, S. R. (1998) · PubMed · Cited by 167
Increased Ethanol Self‐Administration in δ‐Opioid Receptor Knockout Mice
Roberts, A. J., Gold, L. H., Polis, I., McDonald, J. S., Filliol, D., Kieffer, B. L., & Koob, G. F. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02344.x · Cited by 166
Federal Regulation of Methadone Treatment
Rettig, R. A., & Yarmolinsky, A. (2013) · Cited by 165
Levin, F. R., Evans, S. M., McDowell, D. M., & Kleber, H. D. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0605 · Cited by 161
George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R., & Schottenfeld, R. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00310-8 · Cited by 159
Opioid receptor and peptide gene polymorphisms: potential implications for addictions
LaForge, K. S., Yuferov, V. P., & Kreek, M. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00819-0 · Cited by 154
Self-citationEffects of Dopamine D1-like and D2-likeAgonists in Rats that Self-Administer Cocaine
Caine, S. B., Negus, S. S., Mello, N. K., & Bergman, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35108-0 · Cited by 151
Chronic cocaine alters brain mu opioid receptors
Unterwald, E. M., Horne-King, J., & Kreek, M. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90912-s · Cited by 149
Self-citationShippenberg, T. S., LeFevour, A., & Heidbreder, C. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12305-7 · Cited by 149
Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts
Szeto, C. Y.-K., Tang, N. L. S., Lee, D. T. S., & Stadlin, A. (2001) · Neuroreport · doi:10.1097/00001756-200105080-00011 · Cited by 147
Heidbreder, C. A., Goldberg, S. R., & Shippenberg, T. S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90228-f · Cited by 146
Ling, W. W., SHOPTAW, S. J., & Majewska, D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00128-0 · Cited by 144
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys
Mello, N. K., & Negus, S. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37657-8 · Cited by 141
MEDICAL COMPLICATIONS IN METHADONE PATIENTS*
Kreek, M. J. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb16769.x · Cited by 140
Self-citationKampman, K. M., Volpicelli, J. R., Mulvaney, F. D., Alterman, A. I., Cornish, J., Gariti, P., Cnaan, A., Poole, S. A., Muller, E., Acosta, T., et al. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00193-9 · Cited by 140
The GABAB agonist baclofen modifies cocaine self-administration in rats.
Shoaib, M., SWANNER, L. S., Ce, B., Goldberg, & Schindler, C. W. (1998) · PubMed · Cited by 140
Broadbear, J. H., Negus, S. S., Butelman, E. R., de Costa, B. R., & Woods, J. H. (1994) · Psychopharmacology · doi:10.1007/bf02245071 · Cited by 139
Self-citationDesipramine Treatment of Cocaine Dependence in Methadone-Maintained Patients
Arndt, I. O. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110052008 · Cited by 139
Zhou, Y., Spangler, R., LaForge, K. S., Maggos, C. E., Ho, A., & Kreek, M. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20974-0 · Cited by 137
Self-citationBinaltorphimine-related bivalent ligands and their .kappa. opioid receptor antagonist selectivity
Portoghese, P. S., Nagase, H., Lipkowski, A. W., et al. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00399a026 · Cited by 136
Morphine self-administration in µ-opioid receptor-deficient mice
Becker, A., Grecksch, G., Brödemann, R., Kraus, J., Peters, B., Schröeder, H., Thiemann, W., Loh, H. H., & Höllt, V. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000244 · Cited by 135
Opiates, opioids and addiction.
Kreek, M. J. (1996) · PubMed · Cited by 126
Self-citationEffect of a selective dopamine D 1 agonist (ABT-431) on smoked cocaine self-administration in humans
Haney, M., Collins, E. D., Ward, A. S., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050925 · Cited by 121
Rewarding effects of ethanol and cocaine in µ opioid receptor-deficient mice
Becker, A., Grecksch, G., Kraus, J., Loh, H. H., Schröeder, H., & Höllt, V. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0533-2 · Cited by 120
Kling, M. A., Carson, R. E., Borg, L., Zametkin, A., Matochik, J. A., Schluger, J., Herscovitch, P., Rice, K. C., Ho, A., Eckelman, W. C., et al. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39007-x · Cited by 119
Self-citationThe frequency of cocaine administration impacts cocaine-induced receptor alterations
Unterwald, E. M., Kreek, M. J., & Cuntapay, M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02269-7 · Cited by 111
Self-citationWALSH, S. L., Geter-Douglass, B., Strain, E. C., & Bigelow, G. E. (2001) · PubMed · Cited by 109
Cohen, M. R. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010023003 · Cited by 108
Fluoxetine Alters the Effects of Intravenous Cocaine in Humans
WALSH, S. L., Preston, K. L., Sullivan, J. T., FROMME, R., & Bigelow, G. E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00005 · Cited by 107
Disulfiram effects on acute cocaine administration
McCance‐Katz, E. F., Kosten, T. R., & Jatlow, P. L. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00050-7 · Cited by 106
Cocaine Tolerance: Behavioral, Cardiovascular, and Neuroendocrine Function in Men
Mendelson, J. H. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00146-2 · Cited by 106
An Allelic Variation in the Human Prodynorphin Gene Promoter Alters Stimulus‐Induced Expression
Zimprich, A. A., Kraus, J., Wöltje, M., Mayer, P. E., Rauch, E., & Höllt, V. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740472.x · Cited by 104
Cornish, J. L., & Kalivas, P. W. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_05 · Cited by 103
Effects of intravenous cocaine are partially attenuated by haloperidol
Sherer, M. A., Kumor, K. M., & Jaffe, J. H. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90127-3 · Cited by 101
Butelman, E. R., Negus, S. S., Ai, Y., de Costa, B. R., & Woods, J. H. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39577-7 · Cited by 99
Self-citationKreek, M., Ragunath, J., Plevy, S., Hamer, D., Schneider, B., & Hartman, N. (1984) · Neuropeptides · doi:10.1016/0143-4179(84)90081-7 · Cited by 97
Self-citationGerasimov, M. R., Ashby, C. R., Gardner, E. L., Mills, M. J., Brodie, J. D., & Dewey, S. L. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199910)34:1<11::aid-syn2>3.0.co;2-5 · Cited by 96
Imipramine treatment of cocaine abuse: possible boundaries of efficacy
Nunes, E. V., McGrath, P. J., Quitkin, F. M., Ocepek‐Welikson, K., Stewart, J. W., Koenig, T., Wager, S., & Klein, D. F. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01161-6 · Cited by 95
Schluger, J. H., Ho, A., Borg, L., Porter, M., Maniar, S., Gunduz, M., Perret, G., King, A. C., & Kreek, M. J. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03931.x · Cited by 94
Self-citationKreek, M. J., Schluger, J. H., Borg, L., Gunduz, M., & Ho, A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37950-9 · Cited by 93
Self-citationOn federal regulation of methadone treatment
Dole, V. P. (1995) · JAMA · doi:10.1001/jama.274.16.1307 · Cited by 93
Kreek, M. J., Wardlaw, S. L., Hartman, N., Raghunath, J., Friedman, J., Schneider, B., & Frantz, A. G. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90529-5 · Cited by 92
Self-citationKappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
Gmerek, D. E., Dykstra, L. A., & Woods, J. H. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39099-3 · Cited by 91
Schluger, J. H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00222-0 · Cited by 88
Opiate and Cocaine Addictions: Challenge for Pharmacotherapies
Kreek, M. J. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00440-6 · Cited by 87
Self-citationKreek, M. J. (1996) · Neurochemical Research · doi:10.1007/bf02532387 · Cited by 87
Self-citationUr, E., Wright, D. M., Bouloux, P. M., & Grossman, A. B. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700971 · Cited by 84
Chen, A. C. H., LaForge, K. S., Ho, A., McHugh, P. F., Kellogg, S. H., Bell, K., Schluger, R. P., Leal, S. M., & Kreek, M. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10362 · Cited by 84
Self-citationKing, A. C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00416-x · Cited by 81
Naltrexone in the Treatment of Alcohol Dependence: A Combined Analysis of Two Trials
O’Malley, S. S., Croop, R. S., Wroblewski, J. M., Labriola, D., & Volpicelli, J. R. (1995) · Psychiatric Annals · doi:10.3928/0048-5713-19951101-11 · Cited by 81
Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Human Kappa Opioid Receptor
Remmers, A. E., Clark, M. J., Mansour, A., Akil, H., Woods, J. H., & Medzihradsky, F. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38026-7 · Cited by 74
Archer, S., Glick, S. D., & Bidlack, J. M. (1996) · Neurochemical Research · doi:10.1007/bf02532378 · Cited by 73
Ko, M., Butelman, E. R., Traynor, J. R., & Woods, J. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37416-6 · Cited by 70
Self-citationFrom basic science to clinical medicine
Pepe, G. J. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00159-0 · Cited by 70
Neural substrates of opiate reinforcement
Bozarth, M. A., & Wise, R. A. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90027-1 · Cited by 70
Zhou, Y., Franck, J., Spangler, R., Maggos, C. E., Ho, A., & Kreek, M. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04577.x · Cited by 70
Self-citationProdynorphin, proenkephalin and κ opioid receptor mRNA responses to acute “binge” cocaine
Spangler, R., Zhou, Y., Maggos, C. E., Schlussman, S. D., Ho, A., & Kreek, M. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00249-5 · Cited by 66
Self-citationNegus, S. S., Mello, N. K., Linsenmayer, D. C., Jones, R. M., & Portoghese, P. S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1038-x · Cited by 64
Nicotine addiction: insights from recent animal studies
Mathieu-Kia, A.-M., Kellogg, S. H., Butelman, E. R., & Kreek, M. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1096-0 · Cited by 64
Self-citationYuferov, V. P., Zhou, Y., Spangler, R., Maggos, C. E., Ho, A., & Kreek, M. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00155-5 · Cited by 63
Self-citationCocaine Abuse Sharply Reduced in an Effective Methadone Maintenance Program
Borg, L., Broe, D. M., Ho, A., & Kreek, M. J. (1999) · Journal of Addictive Diseases · doi:10.1300/j069v18n04_06 · Cited by 61
Self-citationComparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities.
France, C. P., Medzihradsky, F., & Woods, J. H. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38497-1 · Cited by 59
Wilcox, K. M., Lindsey, K. P., Votaw, J. R., Goodman, M. M., Martarello, L., Carroll, F. I., & Howell, L. (2001) · Synapse · doi:10.1002/syn.10018 · Cited by 59
Sinnott, R. S., Mach, R. H., & Nader, M. A. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00162-8 · Cited by 57
Wang, X., Zhou, Y., Spangler, R., Ho, A., Han, J.-S., & Kreek, M. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00021-2 · Cited by 55
Self-citationGABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine
Gerasimov, M. R., Schiffer, W. K., Gardner, E. L., Marsteller, D. A., Lennon, I. C., Taylor, S. J., Brodie, J. D., Ashby, C. R., & Dewey, S. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00800-7 · Cited by 54
Kosten, T. R., Kreek, M.-J., Ragunath, J., & Kleber, H. D. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90437-6 · Cited by 54
Self-citationCulpepper-Morgan, J. A., & Kreek, M. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90289-4 · Cited by 54
Self-citationVillemagne, V. L., Rothman, R. B., Yokoi, F., Rice, K. C., Matecka, D., Dannals, R. F., & Wong, D. F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199904)32:1<44::aid-syn6>3.0.co;2-9 · Cited by 54
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
Dykstra, L. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12595-0 · Cited by 54
Auditory deprivation modifies sleep in the guinea-pig
Pedemonte, M., Peña, J. L., Torterolo, P., & Velluti, R. A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13392-4 · Cited by 50
Negus, S. S., Mello, N. K., Lamas, X., & Mendelson, J. H. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20676-0 · Cited by 50
Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts
Kosten, T. R., Kreek, M.-J., Ragunath, J., & Kleber, H. D. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90150-2 · Cited by 49
Self-citationAzaryan, A. V., Clock, B. J., Rosenberger, J. G., et al. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y98-023 · Cited by 49
Effect of dopamine receptor antagonists on cocaine subjective effects: A naturalistic case study
Ohuoha, D. C., Maxwell, J. A., Thomson, L. E., Cadet, J. L., & Rothman, R. B. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(96)00161-4 · Cited by 48
Spangler, R., Zhou, Y., Schlussman, S. D., Ho, A., & Kreek, M. J. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)02257-7 · Cited by 47
Self-citationDoty, P., & de Wit, H. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199506000-00009 · Cited by 46
Zhou, Y., Spangler, R., Maggos, C. E., Wang, X., Han, J., Ho, A., & Kreek, M. J. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1630261 · Cited by 46
Self-citationEffect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans
Evans, S. M., WALSH, S. L., LEVIN, F. R., Foltin, R. W., Fischman, M. W., & Bigelow, G. E. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00129-6 · Cited by 45
Kuzmin, A. V., Gerrits, M. A. F. M., & van Ree, J. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00637-2 · Cited by 43
Analgesia produced by E-2078, a systemically active dynorphin analog, in mice.
Nakazawa, T., Furuya, Y., Kaneko, T., Yamatsu, K., Yoshino, H., & Tachibana, S. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20187-2 · Cited by 41
3,4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function
Metzger, R. R., Hanson, G. R., Gibb, J. W., & Fleckenstein, A. E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00196-4 · Cited by 40
Platt, D. M., Rowlett, J. K., & Spealman, R. D. (2001) · Psychopharmacology · doi:10.1007/s002130100779 · Cited by 40
Kolar, A. F., Brown, B. S., Weddington, W. W., Haertzen, C. C., Michaelson, B. S., & Jaffe, J. H. (1992) · International Journal of the Addictions · doi:10.3109/10826089209068770 · Cited by 38
Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment.
Roache, J., Grabowski, J., Schmitz, J. M., Creson, D. L., & Rhoades, H. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00011 · Cited by 38
Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach
(1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)84207-3 · Cited by 37
Zhou, Y., Spangler, R., Maggos, C. E., LaForge, K. S., Ho, A., & Kreek, M. J. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00672-3 · Cited by 36
Self-citationMutschler, N. H., & Bergman, J. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0976-z · Cited by 36
Kosten, T. R., Morgan, C., & Kreek, M.-J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90220-t · Cited by 35
Self-citationMetyrapone‐induced withdrawal symptoms
KENNEDY, J. A., HARTMAN, N., Sbriglio, R., Khuri, E. T., & Kreek, M. J. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03438.x · Cited by 33
Self-citationDouble-Blind Comparison of Bromocriptine and Placebo in Cocaine Withdrawal
Eiler, K., Schaefer, M. R., Salstrom, D., & Lowery, R. (1995) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999509095230 · Cited by 33
Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys.
France, C. P., & Gerak, L. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22568-x · Cited by 31
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Vivian, J. A., DeYoung, M. B., Sumpter, T. L., Traynor, J. R., Lewis, J. W., & Woods, J. H. (1999) · PubMed · Cited by 31
Zhou, Y., Franck, J., Spangler, R., Maggos, C. E., Ho, A., & Kreek, A. M. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200010000-00016 · Cited by 31
Pergolide Mesylate for Cocaine Abuse: A Controlled Preliminary Trial
LEVIN, F. R., McDowell, D. M., Evans, S. M., Brooks, D. J., Spano, C., & Nunes, E. V. (1999) · American Journal on Addictions · doi:10.1080/105504999305929 · Cited by 30
Zhou, Y., Schlussman, S. D., Ho, A., Spangler, R., Fienberg, A. A., Greengard, P., & Kreek, M. J. (1999) · Neuroendocrinology · doi:10.1159/000054476 · Cited by 29
Self-citationPaul, M., Dewey, S. L., Gardner, E. L., Brodie, J. D., & Ashby, C. R. (2001) · Synapse · doi:10.1002/syn.1078 · Cited by 28
Neumeyer, J. L., Gu, X., van Vliet, L. A., DeNunzio, N. J., Rusovici, D. E., Cohen, D. J., Negus, S. S., Mello, N. K., & Bidlack, J. M. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00543-1 · Cited by 28
Butelman, E. R., Harris, T. J., & Kreek, M. J. (1999) · Psychopharmacology · doi:10.1007/s002130051144 · Cited by 28
Self-citationLong-Term Pharmacotherapy for Opiate (Primarily Heroin) Addiction: Opioid Agonists
Kreek, M. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_14 · Cited by 27
Self-citationReinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys
Ranaldi, R., Wang, Z., & Woolverton, W. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00124-7 · Cited by 25
Effects of cyclazocine on cocaine self-administration in rats
Glick, S. D., Visker, K. E., & Maisonneuve, I. M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00548-2 · Cited by 24
Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
Ohnishi, A., Mihara, M., Yasuda, S., Tomono, Y., Hasegawa, J., & Tanaka, T. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22340-0 · Cited by 22
The treatment of alcoholism in France
Batel, P. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01169-y · Cited by 22
Acamprosate as an aid in the treatment of alcoholism.
Chick, J. (1995) · PubMed · Cited by 21
Reliability of Sequential Naloxone Challenge Tests
Rosen, M. I., McMahon, T. J., Margolin, A., Gill, T. S., Woods, S. W., Pearsall, H. R., Kreek, M. J., & Kosten, T. R. (1995) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999509002710 · Cited by 20
Self-citationDynorphin A (1–8) Analog, E-2078, Is Stable in Human and Rhesus Monkey Blood
Yu, J. T., Butelman, E. R., Woods, J. H., Chait, B. T., & Kreek, M. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36529-2 · Cited by 20
Self-citationAcute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects
King, A. C., Ho, A., Schluger, J. H., Borg, L., & Kreek, M. J. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00150-1 · Cited by 18
Self-citationKreek, M. J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_15 · Cited by 13
Self-citationRanaldi, R., Anderson, K. G., Carroll, F. I., & Woolverton, W. L. (2000) · Psychopharmacology · doi:10.1007/s002130000602 · Cited by 12
Zhou, Y., Spangler, R., Ho, A., & Kreek, M. J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00223-6 · Cited by 12
Self-citationCook, C. D., Carroll, F. I., & Beardsley, P. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01501-7 · Cited by 10
Cited by
Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101
Kreek, M. J., Nielsen, D. A., Butelman, E. R., & LaForge, K. S. (2005) · Nature Neuroscience · doi:10.1038/nn1583 · Cited by 1,024
Self-citationThe addicted human brain: insights from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18533 · Cited by 916
Stress dysregulation of drug reward pathways, and the transition to drug dependence
Koob, & Kreek, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05030503 · Cited by 868
Self-citationDrug addiction: the neurobiology of disrupted self-control
Baler, R. D., & Volkow, N. D. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.005 · Cited by 640
Metadata
- Authors
- Kreek, M. J., LaForge, K. S., & Butelman, E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-09-01
- Volume
- 1
- Issue
- 9
- Pages
- 710-726
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2111774737
- Cited by
- 374
- References
- 190
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.